HUTCHMED Initiates Phase II/III Trial with Hengrui | Company

HUTCHMED Initiates Phase II/III Trial with Hengrui | Company Announcement

HUTCHMED Initiates Phase II/III Trial with Hengrui | Company Announcement

investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Related Keywords

Hong Kong , China , Weiguo Su , Ben Atwell Alex Shaw , Zhou Yi , Atholl Tweedie , Hengrui Pharma , Drug Administration , Stock Exchange Of Hong Kong , Linkedin , Nasdaq , China National Reimbursement Drug List , Jiangsu Hengrui Pharmaceuticals Co Ltd Pharma , China Limited , Exchange Commission , Pancreatic Ductal Adenocarcinoma , Florham Park , Chief Executive Officer , Chief Scientific Officer , Cancers Symposium , Orphan Drug Designation , New Drug Application , Drug User Fee Act , Pharma Exec , Securities Litigation Reform Act , Stock Exchange , Hong Kong Limited , Alex Shaw ,